Whittier Trust CO Of Nevada Inc Incyte Corp Transaction History

Whittier Trust CO Of Nevada Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$58.5 - $69.94 $11,700 - $13,988	-200 Reduced 68.97%	90 $6,000
Q3 2018 Oct 23, 2018	SELL	$61.75 - $74.23 $5,557 - $6,680	-90 Reduced 23.68%	290 $20,000
Q2 2018 Jul 27, 2018	BUY	$60.85 - $83.98 $23,123 - $31,912	380 New	380 $25,000
Q2 2018 Jul 20, 2018	SELL	$60.85 - $83.98 $23,123 - $31,912	-380 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$93.56 - $116.6 $18,712 - $23,320	200 Added 111.11%	380 $36,000
Q3 2017 Oct 23, 2017	BUY	$109.15 - $138.27 $19,647 - $24,888	180	180 $21,000

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.